A Retrospective Study in Trans Individuals Undergoing Gender Affirming Testosterone Treatment: Can Changes in Prolactin Counteract the Negative Effects on the Lipid Profile?
<b>Background/Objectives:</b> Gender-affirming hormone therapy (GAHT) is known to influence the lipid profiles of trans men and transmasculine individuals. Recent data show that moderate prolactin (PRL) elevations might exert beneficial metabolic effects (“HomeoFIT-PRL model”). The aim o...
Saved in:
Main Authors: | Jojo Steininger, Katalin Widmann, Ulrike Kaufmann, Marlene Hager, Rodrig Marculescu, Robert Krysiak, Johannes Ott |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/66 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma prolactin axis shift from placental to pituitary origin in late prepartum mice
by: Taku James Sairenji, et al.
Published: (2024-07-01) -
Healthcare practitioners as accomplices: a qualitative study of gender affirmation in a context of ambiguous regulation in Indonesia
by: Benjamin Hegarty, et al.
Published: (2025-01-01) -
Biological roles of growth hormone/prolactin from an evolutionary perspective
by: Yasumasa Iwasaki, et al.
Published: (2024-09-01) -
Gender Affirmation Surgery: Financial Considerations
by: Chloe W. Swearingen, et al.
Published: (2020-12-01) -
Gender Affirmation Surgery: Financial Considerations
by: Chloe W. Swearingen, et al.
Published: (2020-12-01)